Abstract Infants with congenital heart disease (CHD) have delayed brain maturation and alterations in brain volume. Brain metrics is a simple measurement technique that can be used to evaluate brain growth. This study used brain metrics to test the hypothesis that alterations in brain size persist at 3 months of age and that infants with CHD have slower rates of brain growth than control infants.
the last few decades have improved survival [29] . Concerns have now focused on the long-term neurodevelopmental outcomes of these infants, with recognition that challenges occur throughout childhood in the domains of motor function, cognition, language, behavior, attention, visualspatial skills, and academic achievement [3, 4, 16, 20, 24] . To improve outcomes, it is crucial to understand the nature and timing of injury and alterations in cerebral development. Recent behavioral and neuroimaging measures have identified that disturbances are common before surgery, occurring in [50 % of infants with CHD [2, 14, 15, 19, 21, 22] . Magnetic resonance imaging (MRI) studies of the brain have shown first that injury is common, particularly in the form of focal or punctate white matter lesions [2, 21] . Second, there is often maturational delay in cerebral development, as defined by magnetic resonance spectroscopy and diffusion tensor imaging [22] . Cerebral growth, on MRI volumetry, is also impaired and appears to evolve during the final trimester of pregnancy [18, 28] . However, the rate of cerebral growth after surgical correction of CHD lesions has not been evaluated.
MRI cerebral volumetry uses volumetric segmentation analysis that requires manually interactive algorithms to provide a three-dimensional (3D) volume of brain tissue. Although MRI cerebral volumetry may provide a more complete profile of total and regional cerebral growth, such techniques are challenging. Alternatively, cerebral biometry (or brain metrics) is a simple, quantitative method by which to assess cerebral size and growth across multiple regions using standard T2-weighted MRI acquisitions [10, 11] . Brain metrics display good correlation with volumetry in infants [23] , and in the preterm population biparietal diameter relates to cognitive and motor outcomes at 2 years of age [27] . The purpose of this study was to use brain metrics to evaluate brain growth across the first 3 months of life in infants with complex CHD who have undergone surgery. We hypothesized that infants with CHD would display a slower rate of brain growth in their first 3 months of life than control infants, with singleventricle physiology having the greatest alterations in cerebral growth.
Methods

Patients
A prospective longitudinal study was conducted at Starship Children's Hospital in Auckland, New Zealand, between March 2005 and November 2008, and included infants with complex CHD who underwent surgery at \8 weeks of age. Imaging analysis was performed at Washington University in St. Louis, MO. Exclusion criteria were infants \36 weeks gestation or [48 weeks postmenstrual age, presence of a pre-existing neurologic deficit that was not related to the cardiovascular defect, presence of a chromosomal abnormality or syndrome, presence of moderate or severe extracardiac anomalies, history of previous cardiac surgery, need for extracorporeal membrane oxygenation before surgery, and inability to undergo MRI. Informed consent was obtained from all families, and the study was approved by the Ethics Committees of Starship Children's Hospital and Washington University in St Louis.
All infants enrolled were separated into one of four cardiac diagnostic groupings: single-ventricle circulation (SV), single-ventricle circulation with aortic arch anomaly (SVA), two-ventricle circulation (2V), and two-ventricle circulation with aortic arch anomaly (2VA) [6] . Control patients included 36 healthy term infants from Melbourne, Australia, and 23 healthy infants at 3 months of age from St. Louis, MO.
Surgical Management
Anesthesia was induced and maintained with high-dose fentanyl, isofluorane, and muscle relaxants. Near infrared spectroscopy was not used routinely at the time of this study. For the infants who required cardiopulmonary bypass (CPB), the perfusion strategy included continuous full-flow CPB at 150 mL/kg/min. Alpha-stat acid-base management was used above and pH-stat below 30°C. Antegrade cerebral perfusion (ACP) was maintained by way of a Goretex shunt to the innominate artery in all infants undergoing Norwood-type reconstructions. ACP was maintained at flows of 30-40 % of ''full'' CPB flow and adjusted to target a right radial arterial mean pressure of 30-45 mm Hg. Deep hypothermic circulatory arrest (DHCA) was used in infants with biventricular circulation during arch reconstruction and during surgery on the atrial septum. Continuous hemofiltration was used in all patients during CPB, with a target hematocrit of[30 % during CPB and 40-45 % at the completion of CPB. The sternum was left open in all infants undergoing Norwood-type operations when the surgery was complex or when the infant required more than a low dose of vasoactive drug infusions. The sternum was closed in the intensive care unit when hemodynamic stability was achieved. After surgery, analgesia and sedation were managed with continuous infusions of morphine and midazolam.
MRI Methods
MRI Acquisition
Brain MRIs were undertaken before surgery, after surgery, and at 3 months of age. Preoperative and postoperative MRIs were performed when the infants were clinically stable. The 3 month MRI was performed in the outpatient setting. Infants were fed (when clinically appropriate), wrapped, and placed in a vacuum-fixation beanbag to keep them still and supported. MRIs were performed on a 1.5T Magnetom Avanto (Siemens, Erlangen, Germany) and the following sequences were acquired: (1) coronal T2-weighted turbo-spin echo sequences: 2-mm slice thickness; repetition time (TR) = 4510 ms; echo time (TE) = 79 and 158 ms; flip angle = 150°; and field of view (FOV) = 192 9 192; (2) transverse T2-weighted sequences: 3-mm slice thickness; TR = 4140 ms; TE = 158 ms; flip angle = 150°; and FOV = 160 9 160; and (3) coronal 3D-FLAIR T1-weighted images: 1-mm slice thickness; TR = 10 ms; TE = 4.8 ms; flip angle = 15°; and FOV = 192 9 192. Term controls included 36 healthy term infants from Royal Children's Hospital, Melbourne, who underwent MRI using a 1.5T Sigma System MR imaging system (GE Healthcare, Milwaukee, WI) with T2-weighted, dualecho, fast spin-echo sequences; 2 mm slice thickness; TR = 4,000 ms; TE = 60/160 ms; and FOV = 220 9 160 mm. Three-month-old controls were acquired from St. Louis Children's Hospital in St. Louis, MO, for comparison with the 3-month MRI CHD infants. These images were acquired on a 1.5T Magnetom Avanto (Siemens, Erlangen, Germany) with T2-weighted dual-echo, fast/ turbo spin-echo sequences; 3-mm slice thickness; TR = 3500 ms; TE = 115 to 119 ms; and FOV = 256 9 192 mm [1] .
MRI Qualitative Scoring
A standardized qualitative scoring system was applied to the preoperative MRIs by two independent raters (C. O. and T. I.) to evaluate for presence of white-matter focal signal abnormality, delayed myelination in the posterior limb of the internal capsule (PLIC), presence of increased extra-axial space, and delayed maturation of gyrification [13, 30] . The postoperative MRIs were evaluated for whitematter focal signal abnormality only.
MRI Brain Metrics
Simple brain metrics were undertaken using the preoperative and 3-month MRIs on T2-weighted images [23] . Nineteen parameters were measured by two independent raters (L. L. and C. O.). Cerebral tissue measures included right frontal length (RFL), left frontal length (LFL), right frontal height (RFH), left frontal height (LFH), bifrontal diameter (BIFD), bone biparietal diameter (BoBPD), brain biparietal diameter (BrBPD), transverse cerebellar diameter (TCD), and brain stem area (BA) (Fig. 1) . Fluid space measures included third ventricle, interhemispheric distance, right and left extra-axial fluid space, right and left cranio-caudal interopercular distance, right and left anteroposterior interopercular distance, and right-and leftventricular diameter.
Statistical Analysis
Comparisons between the control and CHD populations were performed with two-sample Student t test for continuous variables and chi-square or Fisher's exact test for categorical variables. Postmenstrual age (PMA) of preoperative MRI demonstrated heterogeneity of variance and was therefore evaluated with Mann-Whitney test. For comparison between cardiac diagnostic groupings, analysis of variance with post hoc Bonferroni contrasts was used to evaluate continuous variables, and chi-square test was used to evaluate categorical variables. DHCA time demonstrated heterogeneity of variance and was therefore analyzed using Kruskal-Wallis test. To control for confounders when comparing brain metrics across groups, analysis of covariance was performed.
To evaluate brain growth between the preoperative and 3-month MRIs, the value for each measurement at preoperative MRI was subtracted from the 3-month MRI value to obtain a delta value (delta metric). Because the term controls and 3-month controls were from different populations, comparisons on delta metrics are confounded with random population effects. Therefore, paired Student t test was performed on preoperative and 3-month MRI brain metrics in CHD infants, and the mean change and confidence intervals for the control and CHD populations were estimated to identify differences in brain growth between the two groups.
Three-month MRI brain metrics and delta metrics in CHD infants were further evaluated with simple linear regression to identify relationships to clinical factors. To compensate for the number of variables examined, alpha = 0.01 was used to determine significance on simple regression analysis. Factors meeting this significance value were then included in a stepwise multiple regression model. Alpha = 0.05 was used as the significance level for all other analyses in the study.
Results
Patient Population
Seventy-one infants were consented and enrolled in the study. Four were excluded after enrollment for positive postnatal genetic testing (45XY, der (13; 14) (q10; q10) [n = 1] and absent or poor quality preoperative MRI (n = 3). Ten infants, 9 of whom died before evaluation, did not undergo MRI at 3 months of age. Therefore, these infants were also excluded. Thus, 57 infants with CHD (36 term controls and 23 3-month old controls) were included in this study.
On average, infants with CHD were 1 week younger than controls at the time of preoperative MRI and weighed less than controls at 3 months of age (Table 1 ). There were differences between the cardiac groups for weight at 3-month MRI, with 2V infants weighing more than 2VA infants (p \ 0.05). There were also fewer 2V infants requiring nasogastric (NG) feeds at discharge (p \ 0.01). Regarding surgical variables, differences existed for number of infants requiring CPB (p \ 0.001), number of infants requiring DHCA (p \ 0.01), DHCA time (p \ 0.001), and cross-clamp time (p \ 0.01) ( Table 2 ). These differences were expected given the variation in surgical approach for different cardiac diagnoses. SV infants were less likely to undergo cardiopulmonary bypass; SVA and 2VA infants were more likely to undergo DHCA; 2VA infants were more likely to have longer DHCA time; and 2V and 2VA infants were more likely to have longer crossclamp time.
Qualitative Scoring
Before surgery, focal signal abnormality in cerebral white matter was present in 42 % (n = 23) of infants with CHD. Delayed myelination in the PLIC was present in 42 % (n = 24), increased extra-axial fluid space in 47 % (n = 27), and delayed maturation of gyrification in 63 % (n = 36) of infants. On postoperative MRI, 65 % (n = 37) of infants had focal signal abnormality in the cerebral white matter. There were no differences between cardiac groups for any of these variables.
Brain Metrics
For the preoperative MRI, CHD infants had smaller measures in RFH, LFH, BIFD, BoBPD, BrBPD, TCD, and BA after controlling for sex, PMA at MRI, and birth weight (Table 3) . With the exception of TCD, these differences persisted on 3-month MRI (Table 3 ). There were no significant alterations in other tissue or fluid metrics. On examination between diagnostic groupings, the 2V group trended toward a greater BA than infants with other cardiac diagnoses (p = 0.08) before surgery. There were no differences between groups for the 3-month MRI.
Brain Growth
From term to 3 months of age, there was no difference in growth in any of the brain tissue measures between CHD infants and controls. However, cerebellar growth neared significance, with CHD infants demonstrating greater growth (Table 4) . Because the term and 3-month controls came from two different populations, we were unable to control for potential confounders; however, delta metrics of CHD infants were evaluated in relation to clinical factors as described later in the text. There were no differences in brain growth between cardiac groupings.
Predictors of Brain Size at 3 Months
Simple regression was performed on clinical factors (Table 5) , and those with p \ 0.01 were included in a stepwise multiple regression model. On multiple regression analysis, 31 % of the variance in BoBPD was explained by weight at 3 months of age (R 2 = 0.25, p \ 0.001) and head circumference at birth (R 2 = 0.06, p \ 0.05). For BrBPD, 37 % of the variance was explained by weight at 3 months of age (R 2 = 0.21, p \ 0.001), head circumference at birth (R 2 = 0.08, p \ 0.05), and duration of mechanical ventilation (R 2 = 0.08, p \ 0.05). For TCD, 67 % of the variance was explained by weight at 3 months of age 
Predictors of Brain Growth
Simple regression was performed on delta metrics and clinical factors (Table 6) , and those with p \ 0.01 were included in a stepwise multiple regression model. Duration of mechanical ventilation, delayed myelination in the PLIC, and increased extra-axial space all trended toward predicting growth in frontal lobe measures but did not meet criteria for inclusion in the final model. For delta BoBPD, the model included delta weight and age at 3-month MRI, but the only significant predictor was delta weight (R 2 = 0.30, p \ 0.001). For delta BrBPD, 31 % of the variance was explained by delta weight (R 2 = 0.22, p \ 0.001) and duration of mechanical ventilation (R 2 = 0.09, p \ 0.05).
For delta TCD, 65 % of the variance was explained by delta weight (R 2 = 0.38, p \ 0.001), age at 3-month MRI (R 2 = 0.15, p \ 0.001), and duration of mechanical ventilation (R 2 = 0.12, p \ 0.01).
Discussion
This study is the first to evaluate longitudinal brain growth in CHD infants. Previous studies have used volumetry to evaluate brain volumes, demonstrating alterations in total brain volume and intracranial cavity volume in the third trimester of pregnancy and altered gray-matter volume at 15 months of age [18, 28] . Cerebral biometry, or brain metrics, has been used in the fetal setting to evaluate brain size [10] . In preterm infants at term gestation, brain metrics have correlated with volumetric analysis [23] and have related to neurodevelopmental outcome [27] . The results of our study have demonstrated smaller brain metrics across multiple regions of the brain in infants with CHD. This is consistent with previously published volumetry data, supporting decreased brain size in infants with CHD. We found that although infants with CHD continue to have a smaller brain size than controls, they appear to have the same rates of brain growth as healthy term infants during the first 3 months of life after surgical repair. This indicates that brain growth rates in infants with CHD were not adversely affected by surgical intervention and indeed surgery may have permitted more typical rates of cerebral growth.
Although there were multiple clinical factors that related to brain growth, somatic growth appeared to be the predominant factor contributing to brain size at 3 months of age and to brain growth from term to 3 months of age. Operative factors and brain injury, in the form of focal white-matter signal abnormalities, did not relate to brain growth.
Poor somatic growth is known to occur in infants with CHD, with optimization of growth occurring 12-24 months after surgery with early surgical repair and after stage 2 palliation for single-ventricle physiology [5, 26] . The relationship between somatic growth and neurological outcome has not been fully investigated in infants with CHD but has been well described in the preterm population [7] [8] [9] . Slower growth velocity has been shown to increase the likelihood of neurodevelopmental impairment [8] . Head circumference has also been shown to relate to outcome in preterm infants, specifically motor outcomes at 5 years of age [9] and verbal and performance IQ scores, language skills, and hyperactivity at 8 years of age [12] . In our study, head circumference at birth did relate to brain size at 3 months of age but not to brain growth, suggesting that somatic growth may be a better predictor of longitudinal cerebral growth and, ultimately, long-term outcome than head circumference at birth in infants with CHD.
One region, the cerebellum, demonstrated normalization of size by 3 months of age. To our knowledge, the cerebellum has not been well studied in infants with CHD. In preterm infants at term, cerebellar volume is smaller than in term-born infants [17, 25] . The cerebellum also has a significantly faster rate of growth than the cerebral hemispheres in this population, and its size positively correlates with postnatal growth. Similar to the preterm population, we have shown a strong relationship between somatic growth and cerebellar growth. This relationship also exists in the parietal lobe and trends toward a relationship in the frontal lobe. Compared with the preterm population, our infants displayed normalization of cerebellar measures. The rapid rate of cerebellar growth in the newborn period may explain this catch-up growth, particularly in infants with optimal somatic growth. Thus, it seems plausible that optimizing nutrition may allow catch-up growth within the frontal and parietal regions as well. Importantly, this suggests a link between somatic growth, brain growth, and neurological outcome in infants with CHD.
Limitations
The primary limitation to our study was that our 3-monthold control infants came from a different population than the term control infants. Our statistical methods did allow us to adequately compare growth across the first 3 months of life in control and CHD infants, but we were restricted in the capacity to include confounders. Given our preoperative and 3-month MRI results after controlling for confounders, it seems unlikely that inclusion of these variables in the analysis would alter our findings. Nonetheless, it still remains a limitation to our study. In addition, chromosomal abnormalities or genetic syndromes may predispose an infant not only to alterations in somatic growth but also to cerebral abnormalities. Infants with chromosomal abnormalities or syndromes were excluded from this study. However, routine genetic evaluations were not performed on all infants in our cohort, only those with cardiac lesions known to be associated with genetic abnormalities (i.e., FISH for 22q11 deletion). Therefore, some infants may have had unidentified genetic abnormalities that would place them at risk for alterations in brain growth.
Conclusion
In conclusion, our study provides evidence that although infants with CHD have smaller brain size than healthy term infants, cerebral growth rates are comparable with controls. Importantly, the cerebellum even shows catch-up growth. In addition, we have shown a strong relationship between somatic growth and brain growth, emphasizing the importance of early and optimal nutritional intake in CHD infants. Because this study only provides information during the first 3 months of life, further investigation is required to determine the ability of other regions of the brain to catch up and to evaluate how this may relate to outcome.
